View Our Conference Code of Conduct
Join us for the SynGAP Research Fund’s SYNGAP1 Conference 2022: Charting Our Rare Disease Treatment Path
Scientific Meeting: Thursday, December 1
Caregiver Connect: Friday, December 2
Who: SYNGAP1 families, doctors, scientists, researchers, & industry reps
What: A two-day conference, with scientific meeting (Thursday, December 1) & family meeting (Friday, December 2)
When: December 1st & 2nd, 2022
Where: Holiday Inn Express & Conference Center, 920 Broadway, Nashville, TN 37203
Why: SRF will be holding a SYNGAP1 scientific meeting for SYNGAP1 parents, scientists, researchers, & other industry. We’ve added a special non-science family meeting the following day!
Contact us at email@example.com for sponsorship opportunities.
Thursday, December 1 from 8am-5pm
The conference is intended to bring rare disease stakeholders across the research and regulatory spectrum together to discuss research interventions of interest to the SYNGAP1 community and develop a road map for next steps in trial design for therapeutics for SYNGAP1. Audience members are expected to include SYNGAP1 parents, SYNGAP1 researchers, and other rare disease parents and researchers interested in learning novel science and research regulatory aspects of rare diseases that can inform SYNGAP1 treatment development.
8:00-8:10am Welcome. Mike Graglia, MBA, MA, SynGAP Research Fund Managing Director
Session #1: The State of Rare Disease Gene Based Trials. Moderator: Ingrid Scheffer, AO, MBBS, PhD (University of Melbourne)
Session #2: Defining the SYNGAP1 Clinical Spectrum: Identifying Outcomes for Preclinical and Clinical Trials. Moderator: Ingo Helbig, MD
(Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine)
Session #3: Key Efforts within SynGAP Pre-clinical Models. Moderator: Rick Huganir (Johns Hopkins University)
Session #4: Designing a Trial. Moderator: Annapurna Poduri, MD, MPH (Boston Children’s Hospital and Harvard Medical School)
Friday, December 2, 2022